Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-20

Clinical Trial Update: Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares continuing versus interrupting metformin after coronary angiography in patients with acute coronary syndrome or unstable ang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Saskatchewan | Conditions: Acute Coronary Syndrome, Unstable Angina | Phase 4 | Status: UNKNOWN